E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/11/2006 in the Prospect News Biotech Daily.

TLCVision sells 800,000 shares, reduces OccuLogix ownership to 49%

By Elaine Rigoli

Tampa, Fla., April 11 - TLC Vision Corp. has reduced its ownership in OccuLogix, Inc. to 49% after selling 800,000 shares of stock Tuesday on the Toronto Stock Exchange.

The company now has approximately 20.7 million shares.

"Our principal short-term goal was to stop consolidating OccuLogix's financial results and with today's sale that goal has been achieved," president and chief executive officer Jim Wachtman said in a news release.

Based in St. Louis, TLCVision is an eye-care services company providing eye doctors with the tools and technologies necessary for patient care.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.